Are Wegovy and Ozempic the same thing?

They are the same active drug — semaglutide, from Novo Nordisk. Each is sold as a once-weekly injection and, since 2026, as a once-daily tablet. They differ in brand, maximum dose (Wegovy injection 2.4 mg, up to 7.2 mg in adults for weight; Ozempic injection 2 mg), and FDA-approved use (Wegovy for weight management, Ozempic for type 2 diabetes).

Can I use Ozempic for weight loss instead of Wegovy?

Ozempic is not FDA-approved for weight management, though it contains the same molecule as Wegovy and weight loss is a common secondary effect. Prescribing it for weight is an off-label decision only a clinician can make, and coverage often differs. Discuss it with your doctor.

Which causes more weight loss, Wegovy or Ozempic?

Wegovy, because it's dosed higher (2.4 mg) and studied for weight — about 15% average body-weight reduction in the STEP 1 trial. Ozempic at diabetes doses generally produces less. Results are trial averages and vary by person.

Wegovy vs Ozempic

By the pharmaranks editorial teamReviewed against FDA prescribing information (DailyMed) + pivotal trials (PubMed) sourcesUpdated Jul 3, 2026How we research

Same drug — semaglutide — sold as two brands. Ozempic is FDA-approved for type 2 diabetes; Wegovy for chronic weight management, at a higher maximum dose.

At a glance

Attribute	Wegovy	Ozempic
Active drug	semaglutide	semaglutide
Drug class	GLP-1 receptor agonist	GLP-1 receptor agonist
FDA-approved for	Chronic weight management	Type 2 diabetes
How it's taken	Once-weekly injection or once-daily tablet	Once-weekly injection or once-daily tablet
Maker	Novo Nordisk	Novo Nordisk

Wegovyrating & safety →·Ozempicrating & safety →

The short version

Wegovy and Ozempic are the same active medicine — semaglutide, from Novo Nordisk. Both are best known as a once-weekly injection, and since 2026 both are also sold as a once-daily tablet. The difference isn't the molecule; it's the brand, the maximum dose, and the FDA-approved use.

The key difference

Ozempic is approved to treat type 2 diabetes (injection up to 2 mg per week) and, in some adults, to lower cardiovascular risk — weight loss is a secondary effect. Wegovy is approved for chronic weight management (injection maintenance 2.4 mg per week, and the label permits going to 7.2 mg in adults for weight reduction) and carries its own cardiovascular indication. So a person's diagnosis, goal, and insurance — not a difference in the drug — usually decide which brand is prescribed.

What the trials showed on weight

In its pivotal weight trial (STEP 1), Wegovy produced about a 15% average body-weight reduction over 68 weeks. Ozempic's weight loss, at its lower diabetes doses, is generally smaller — though it is the identical molecule. These are trial averages; individual results vary. This is general information, not medical advice.

Bottom line

If the question is “which is better for weight loss,” Wegovy is the version FDA-approved and dosed for it. If it's “are they interchangeable,” they're the same drug but not the same product — dose and approved use differ, and only a clinician should start, switch, or dose them.

Frequently asked

Are Wegovy and Ozempic the same thing?: They are the same active drug — semaglutide, from Novo Nordisk. Each is sold as a once-weekly injection and, since 2026, as a once-daily tablet. They differ in brand, maximum dose (Wegovy injection 2.4 mg, up to 7.2 mg in adults for weight; Ozempic injection 2 mg), and FDA-approved use (Wegovy for weight management, Ozempic for type 2 diabetes).
Can I use Ozempic for weight loss instead of Wegovy?: Ozempic is not FDA-approved for weight management, though it contains the same molecule as Wegovy and weight loss is a common secondary effect. Prescribing it for weight is an off-label decision only a clinician can make, and coverage often differs. Discuss it with your doctor.
Which causes more weight loss, Wegovy or Ozempic?: Wegovy, because it's dosed higher (2.4 mg) and studied for weight — about 15% average body-weight reduction in the STEP 1 trial. Ozempic at diabetes doses generally produces less. Results are trial averages and vary by person.

Compare more GLP-1 options

Mounjaro vs Ozempic Zepbound vs Wegovy Zepbound vs Mounjaro Rybelsus vs Ozempic Mounjaro vs Wegovy All GLP-1 drugs compared →

Sources

General information, not medical advice, and not a substitute for your clinician. Efficacy figures are pivotal-trial averages — individual results, side effects, and cost vary. Only a licensed healthcare professional can choose, start, switch, or dose these medicines.